Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Shelley Moves Up To Chair Canadian Association

Apotex Canada President Becomes CGPA Chair; Sandoz’ Robidoux Elected Vice-Chair

Executive Summary

Canada’s CGPA has named Ray Shelley, president of Apotex Canada, as the off-patent industry association’s chair. At the same time, Sandoz Canada president and general manager Michel Robidoux has been elected vice-chair.

You may also be interested in...



Generics Are 45% Cheaper In Canada Than In 11 Key Markets

Despite increased pressures from inflation and dependence on international supply chains, the average cost of generics in Canada is 45% lower than in 11 comparator countries, the CGPA reports.

Sandoz Highlights Shortages Risk For Essential Drugs In Canada

With Sandoz Canada having just announced its first list of the top 100 most important medicines for Canadian patients, the company has also highlighted the high risk of shortages for 25 of these drugs. Michel Robidoux, president and general manager at Sandoz Canada, gives Generics Bulletin the details in an exclusive Q&A.

Canadian Generics Group Launches Cost-Saving Campaign

The CGPA is drawing attention to the cost savings Canadians can benefit from through the use of generic drugs via a PSA-style digital campaign.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

GB153324

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel